Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA

This article was originally published in The Gray Sheet

Executive Summary

Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group

You may also be interested in...

Regulatory News In Brief

J&J's Sedasys appeal docket

Regulatory News In Brief

J&J's Sedasys appeal docket

Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan

As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts